GeneNeer

GeneNeer

Private
ShohamHealthcare & Life Scienceshttps://geneneer.com

Last Round

Seed

Jan 9, 2024

Total Funding Raised

$1M

Momentum Score

25 /100

Company Overview

GeneNeer is an agritech company that develops gene-editing platforms for smart and fast crop breeding to address the impacts of climate change.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

computational breedingagricultural biotechnologyagritechtrait discoveryaccelerated breedingprecision breedingnon-GMO breedinggene expressioncrop geneticstechnology licensinggenomic analysisseed developmentR&D partnershipspotato breedingAI for agriculture

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GeneNeer Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

GeneNeer Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJan 9, 2024

Key People

Founding team and executive leadership

Kinneret Shefer

Chief Executive Officer Cofounder

Founding Team

GeneNeer Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2025

    Gusui Wu joins as Senior Scientific Advisor.

GeneNeer Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GeneNeer Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GeneNeer's valuation, stock price, and market status.

Firmographic Details

HeadquartersShoham
Employee Range9
Year Founded2016
Last FundingJan 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.